Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ex Vivo Culture Models of Hidradenitis Suppurativa for Defining Molecular Pathogenesis and Treatment Efficacy of Novel Drugs

Inflammation(2022)10.1007/s10753-022-01629-wSource: DataRank Database

Ex Vivo Culture Models of Hidradenitis Suppurativa for Defining Molecular Pathogenesis and Treatment Efficacy of Novel Drugs is a research paper published in Inflammation (2022). On theSindex it has a DataRank of 0. It has been cited 9 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access9 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: greenTopics (24)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Mahendra Kashyap ORCID,Jasim Khan ORCID,Rajesh Sinha ORCID,Zhiping Weng ORCID,Allen S. W. Oak ORCID

Live enrichment

PubMed:35301634 PMC:PMC9940461

National Institutes of Health

Grant: RO1 ES026219

National Cancer Institute

Grant: 5P01CA210946

NCI NIH HHS

Grant: P01 CA210946

NIEHS NIH HHS

Grant: R01 ES026219

National Institutes of Health

Grant: 5P01CA210946-04

RXR Rexinoids for Cancer Chemoprevention

National Institutes of Health

Grant: 1R01ES026219-01A1

Chemoprevention of environmental UVB-induced skin cancer in immunosuppressed mice

greenLicense: CC BY

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9940461

publisherhttps://link.springer.com/content/pdf/10.1007/s10753-022-01629-w.pdf

publisherhttps://link.springer.com/article/10.1007/s10753-022-01629-w/fulltext.html

https://doi.org/10.21203/rs.3.rs-1075860/v1

https://www.researchsquare.com/article/rs-1075860/v1.pdf?c=1638312699000

Fields of Study

0301 basic medicine03 medical and health sciences0302 clinical medicineAnimalsCytokinesHidradenitis SuppurativaKeratinocytesSkinTreatment Outcome

MeSH Terms

KeratinocytesSkinAnimalsHidradenitis SuppurativaCytokinesTreatment Outcome

Keywords

Hidradenitis SuppurativaCytokines/chemokinesEx Vivo ModelsDrug Screening.KeratinocytesTreatment OutcomeAnimalsCytokinesSkin

Sustainable Development Goals

SDG 3: 3. Good health

Ex Vivo Culture Models of Hidradenitis Suppurativa for Defining Molecular Pathogenesis and Treatment Efficacy of Novel Drugs

FAIR Checklist

Authors (14)

Funding (6 grants)

Open Access

Topics

Annotations (Europe PMC)